Cargando…
Enteral feeding is associated with longer survival in the advanced stages of prion disease
To report the frequency, complications, survival and motivations for enteral feeding in UK patients with prion diseases. We analysed data from an ongoing prospective observational cohort study of UK patients with prion diseases (n = 635). Gastrostomy-treated cases were matched by age, gender, diseas...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425295/ https://www.ncbi.nlm.nih.gov/pubmed/32954259 http://dx.doi.org/10.1093/braincomms/fcz012 |
_version_ | 1783570470234226688 |
---|---|
author | McNiven, Kirsty Nihat, Akin Mok, Tze How Tesfamichael, Selam O’Donnell, Veronica Rudge, Peter Collinge, John Mead, Simon |
author_facet | McNiven, Kirsty Nihat, Akin Mok, Tze How Tesfamichael, Selam O’Donnell, Veronica Rudge, Peter Collinge, John Mead, Simon |
author_sort | McNiven, Kirsty |
collection | PubMed |
description | To report the frequency, complications, survival and motivations for enteral feeding in UK patients with prion diseases. We analysed data from an ongoing prospective observational cohort study of UK patients with prion diseases (n = 635). Gastrostomy-treated cases were matched by age, gender, disease aetiology, severity, duration and a genetic predictor of survival (ratio 1:3.1). The main outcome was survival (unadjusted log-rank test); secondary outcomes were future functional impairments, complications and retrospective carer interviews to determine qualitative benefits and motivations. Enteral feeding is uncommon in UK patients with prion diseases (n = 26/635; 4.1%), but more frequent in acquired (7/41, 17.1%) and inherited (7/128, 5.5%) compared with sporadic disease (12/466, 2.6%; P = 3 × 10(−5) chi-squared), and used mostly at advanced stages. Enteral feeding was complicated by infection and the need for reinsertions, but associated with markedly longer survival at advanced neurodisability (median 287 days, range 41–3877 versus 17 days, range 0–2356; log-rank test in three aetiologies each P < 0.01). Interviews revealed different motivations for enteral feeding, including perceived quality of life benefits. We provide Class II evidence that enteral feeding prolongs the akinetic-mute phase of all aetiological types of prion disease. These data may help support decision making in palliative care. Enteral feeding is an important potential confounder in prion disease clinical trials that use survival as an endpoint. |
format | Online Article Text |
id | pubmed-7425295 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-74252952020-09-17 Enteral feeding is associated with longer survival in the advanced stages of prion disease McNiven, Kirsty Nihat, Akin Mok, Tze How Tesfamichael, Selam O’Donnell, Veronica Rudge, Peter Collinge, John Mead, Simon Brain Commun Original Article To report the frequency, complications, survival and motivations for enteral feeding in UK patients with prion diseases. We analysed data from an ongoing prospective observational cohort study of UK patients with prion diseases (n = 635). Gastrostomy-treated cases were matched by age, gender, disease aetiology, severity, duration and a genetic predictor of survival (ratio 1:3.1). The main outcome was survival (unadjusted log-rank test); secondary outcomes were future functional impairments, complications and retrospective carer interviews to determine qualitative benefits and motivations. Enteral feeding is uncommon in UK patients with prion diseases (n = 26/635; 4.1%), but more frequent in acquired (7/41, 17.1%) and inherited (7/128, 5.5%) compared with sporadic disease (12/466, 2.6%; P = 3 × 10(−5) chi-squared), and used mostly at advanced stages. Enteral feeding was complicated by infection and the need for reinsertions, but associated with markedly longer survival at advanced neurodisability (median 287 days, range 41–3877 versus 17 days, range 0–2356; log-rank test in three aetiologies each P < 0.01). Interviews revealed different motivations for enteral feeding, including perceived quality of life benefits. We provide Class II evidence that enteral feeding prolongs the akinetic-mute phase of all aetiological types of prion disease. These data may help support decision making in palliative care. Enteral feeding is an important potential confounder in prion disease clinical trials that use survival as an endpoint. Oxford University Press 2019-09-10 /pmc/articles/PMC7425295/ /pubmed/32954259 http://dx.doi.org/10.1093/braincomms/fcz012 Text en © The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article McNiven, Kirsty Nihat, Akin Mok, Tze How Tesfamichael, Selam O’Donnell, Veronica Rudge, Peter Collinge, John Mead, Simon Enteral feeding is associated with longer survival in the advanced stages of prion disease |
title | Enteral feeding is associated with longer survival in the advanced stages of prion disease |
title_full | Enteral feeding is associated with longer survival in the advanced stages of prion disease |
title_fullStr | Enteral feeding is associated with longer survival in the advanced stages of prion disease |
title_full_unstemmed | Enteral feeding is associated with longer survival in the advanced stages of prion disease |
title_short | Enteral feeding is associated with longer survival in the advanced stages of prion disease |
title_sort | enteral feeding is associated with longer survival in the advanced stages of prion disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425295/ https://www.ncbi.nlm.nih.gov/pubmed/32954259 http://dx.doi.org/10.1093/braincomms/fcz012 |
work_keys_str_mv | AT mcnivenkirsty enteralfeedingisassociatedwithlongersurvivalintheadvancedstagesofpriondisease AT nihatakin enteralfeedingisassociatedwithlongersurvivalintheadvancedstagesofpriondisease AT moktzehow enteralfeedingisassociatedwithlongersurvivalintheadvancedstagesofpriondisease AT tesfamichaelselam enteralfeedingisassociatedwithlongersurvivalintheadvancedstagesofpriondisease AT odonnellveronica enteralfeedingisassociatedwithlongersurvivalintheadvancedstagesofpriondisease AT rudgepeter enteralfeedingisassociatedwithlongersurvivalintheadvancedstagesofpriondisease AT collingejohn enteralfeedingisassociatedwithlongersurvivalintheadvancedstagesofpriondisease AT meadsimon enteralfeedingisassociatedwithlongersurvivalintheadvancedstagesofpriondisease |